Taiwan’s Anbogen inks deal with BeiGene to evaluate combination therapy in colorectal cancer
Anbogen, a Taiwan-based clinical-stage biotech startup, has announced a drug supply collaboration to evaluate the combination of Anbogen’s HDAC …Read More
The Heartbeat of World events
Anbogen, a Taiwan-based clinical-stage biotech startup, has announced a drug supply collaboration to evaluate the combination of Anbogen’s HDAC …Read More